Pittman Quentin J
Dept of Physiology and Pharmacology, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, T2N4N1, Canada.
Epilepsy Res. 2020 Oct;166:106409. doi: 10.1016/j.eplepsyres.2020.106409. Epub 2020 Jun 29.
The ketogenic diet has been used to treat intractable epilepsy for many years, yet the mechanism(s) underlying its effectiveness have not been completely elucidated. However, emerging evidence indicates that the ketogenic diet may correct or otherwise alter a 'dystopic' gut microbiota that exhibits altered fecal microbial composition compared to healthy individuals. Recent studies in animal seizure models also reveal altered gut microbiome, as well as changes in the composition of the microbiota after ingestion of a ketogenic diet. The effectiveness of the ketogenic diet in these animal models appears to be absolutely dependent upon the presence of gut microbiota. Further evidence suggests that effectiveness of the ketogenic diet in controlling seizures may be reliant upon the ability of specific bacterial populations to alter gamma glutamylation of amino acids and thus alter their uptake into the central nervous system. These studies suggest new directions for research in patients with epilepsy.
生酮饮食已被用于治疗难治性癫痫多年,但其有效性背后的机制尚未完全阐明。然而,新出现的证据表明,生酮饮食可能纠正或以其他方式改变与健康个体相比粪便微生物组成发生改变的“异位”肠道微生物群。最近在动物癫痫模型中的研究还揭示了肠道微生物群的改变,以及摄入生酮饮食后微生物群组成的变化。生酮饮食在这些动物模型中的有效性似乎绝对依赖于肠道微生物群的存在。进一步的证据表明,生酮饮食控制癫痫发作的有效性可能依赖于特定细菌群体改变氨基酸γ-谷氨酰化从而改变其进入中枢神经系统的能力。这些研究为癫痫患者的研究指明了新方向。